Evolution and Clinical Advances of Platelet-Rich Fibrin in Musculoskeletal Regeneration
Authors:
- Ragunanthan NarayanaswamyRNRagunanthan Narayanaswamy
- Bishnu Prasad PatroBPBishnu Prasad Patro
- Naveen JeyaramanNJNaveen Jeyaraman
- Prakash GangadaranPrakash Gangadaran
- Ramya Lakshmi RajendranRamya Lakshmi Rajendran
- Arulkumar NallakumarasamyANArulkumar Nallakumarasamy
- Madhan JeyaramanMadhan Jeyaraman
- Prasanna RamaniPRPrasanna Ramani
- Byeong-Cheol AhnByeong-Cheol Ahn
Top Cited Papers
Open Access
- 3 January 2023
- journal article
- review article
- Published by MDPI AG in Bioengineering
- Vol. 10 (1) , 58
Abstract
Over the past few decades, various forms of platelet concentrates have evolved with significant clinical utility. The newer generation products, including leukocyte-platelet-rich fibrin (L-PRF) and advanced platelet-rich fibrin (A-PRF), have shown superior biological properties in musculoskeletal regeneration than the first-generation concentrates, such as platelet-rich plasma (PRP) and plasma rich in growth factors. These newer platelet concentrates have a complete matrix of physiological fibrin that acts as a scaffold with a three-dimensional (3D) architecture. Further, it facilitates intercellular signaling and migration, thereby promoting angiogenic, chondrogenic, and osteogenic activities. A-PRF with higher leukocyte inclusion possesses antimicrobial activity than the first generations. Due to the presence of enormous amounts of growth factors and anti-inflammatory cytokines that are released, A-PRF has the potential to replicate the various physiological and immunological factors of wound healing. In addition, there are more neutrophils, monocytes, and macrophages, all of which secrete essential chemotactic molecules. As a result, both L-PRF and A-PRF are used in the management of musculoskeletal conditions, such as chondral injuries, tendinopathies, tissue regeneration, and other sports-related injuries. In addition to this, its applications have been expanded to include the fields of reconstructive cosmetic surgery, wound healing in diabetic patients, and maxillofacial surgeries.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2021R1I1A1A01040732, NRF-2022R1I1A1A01068652)
This publication has 95 references indexed in Scilit:
- In vivo evaluation of titanium-prepared platelet-rich fibrin (T-PRF): a new platelet concentrateBritish Journal of Oral and Maxillofacial Surgery, 2013
- Mechanisms of fibrin polymerization and clinical implicationsBlood, 2013
- Platelet-Rich Fibrin Matrix for Facial Plastic SurgeryFacial Plastic Surgery Clinics of North America, 2012
- Incorporation of exudates of human platelet‐rich fibrin gel in biodegradable fibrin scaffolds for tissue engineering of cartilageJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2012
- Platelet-Rich Plasma Therapy: A Systematic Literature Review and Evidence for Clinical UseThe Physician and Sportsmedicine, 2011
- Platelet-Rich fibrin: A second generation platelet concentrate and a new friend of oral and maxillofacial surgeonsAnnals of Maxillofacial Surgery, 2011
- Platelet-Rich Fibrin Constructs Elute Higher Concentrations of Transforming Growth Factor-β1 and Increase Tendon Cell Proliferation Over Time when Compared to Blood Clots: A Comparative In Vitro AnalysisVeterinary Surgery, 2010
- Blood‐derived biomaterials: fibrin sealant, platelet gel and platelet fibrin glueISBT Science Series, 2009
- Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III: Leucocyte activation: A new feature for platelet concentrates?Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2006
- Longitudinal characterization of synovial fluid biomarkers in the canine meniscectomy model of osteoarthritisJournal of Orthopaedic Research, 2000